|
| InsiderPie Expert Score
| P/E ratio
| Net margin
| ROA
| Net income per employee
|
| IQVIA Holdings Inc.
|
trending_flat
49
/ 100
| 22
| 7.9%
| 4.3%
| €11.93K
|
| Intelligent Bio Solutions Inc.
|
trending_flat
50
/ 100
| -0.99
| -346.2%
| -128.1%
| -€181.36K
|
| Vimian Group AB (publ)
|
trending_flat
50
/ 100
| 81
| 5.6%
| 2.0%
| €18.90K
|
| Fulgent Genetics, Inc.
|
trending_flat
51
/ 100
| -12
| -16.8%
| -4.3%
| -€33.34K
|
| Lumibird SA
|
trending_flat
50
/ 100
| 26
| 3.1%
| 3.0%
| €12.48K
|
| NanoRepro AG
|
trending_flat
50
/ 100
| -2.1
| -55.9%
| -24.6%
| -€444.52K
|
| Exagen Inc.
|
trending_flat
50
/ 100
| -9
| -28.8%
| -28.9%
| -€69.71K
|
| Verici Dx plc
|
trending_flat
50
/ 100
| -0.23
| -368.2%
| -132.3%
| -€723.52K
|
| Proteome Sciences plc
|
trending_flat
50
/ 100
| -1.6
| -0.0%
| -63.5%
| -€186.94K
|
| Illumina, Inc.
|
trending_down
59
/ 100
| 12
| 29.4%
| 20.7%
| €120.33K
|
| IDEXX Laboratories, Inc.
|
trending_up
72
/ 100
| 43
| 24.4%
| 29.6%
| €76.88K
|
| Enzo Biochem, Inc.
|
trending_flat
48
/ 100
| -0.78
| -76.7%
| -33.2%
| -€144.71K
|
| Myriad Genetics, Inc.
|
trending_flat
50
/ 100
| -1.2
| -47.4%
| -58.3%
| -€125.59K
|
| Exact Sciences Corporation
|
trending_flat
53
/ 100
| -10
| -34.2%
| -17.3%
| -€125.00K
|
| Medpace Holdings, Inc.
|
trending_down
59
/ 100
| 21
| 18.7%
| 26.6%
| €60.83K
|
| Standard BioTools Inc.
|
trending_flat
50
/ 100
| -3.4
| -78.2%
| -22.9%
| -€185.22K
|
| Waters Corporation
|
trending_down
65
/ 100
| 32
| 21.7%
| 14.0%
| €74.67K
|
| Trinity Biotech plc
|
trending_flat
50
/ 100
| -0.38
| -51.6%
| -30.8%
| -€71.78K
|
| Meridian Bioscience, Inc.
|
trending_flat
50
/ 100
| -548
| -0.9%
| -0.6%
| -€3.36K
|
| Interpace Biosciences, Inc.
|
trending_flat
50
/ 100
| 0.63
| 11.4%
| 42.0%
| €40.03K
|
| Mettler-Toledo International Inc.
|
trending_down
60
/ 100
| 29
| 21.5%
| 24.4%
| €44.50K
|
| Star Equity Holdings, Inc.
|
trending_flat
46
/ 100
| -0.99
| -9.7%
| -6.4%
| -€28.89K
|
| Precipio, Inc.
|
trending_flat
50
/ 100
| -9.1
| -8.8%
| -9.6%
| -€28.62K
|
| PerkinElmer, Inc.
|
trending_flat
52
/ 100
| 49
| 10.9%
| 2.4%
| €15.06K
|
| ANGLE plc
|
trending_flat
50
/ 100
| -1.5
| -497.0%
| -55.9%
| -€109.12K
|
| Biocept, Inc.
|
trending_flat
50
/ 100
| -0.013
| 1,015.8%
| -157.9%
| -€598.92K
|
| Synlab AG
|
trending_flat
50
/ 100
| 27
| 3.4%
| 1.9%
| €3.31K
|
| OPKO Health, Inc.
|
trending_flat
50
/ 100
| -5.9
| -26.7%
| -9.0%
| -€50.71K
|
| Bionano Genomics, Inc.
|
trending_flat
50
/ 100
| -0.15
| -271.0%
| -97.8%
| -€650.77K
|
| Aclaris Therapeutics, Inc.
|
trending_flat
50
/ 100
| -1.2
| -802.0%
| -71.2%
| -€1.89M
|
| Biocartis Group NV
|
trending_flat
50
/ 100
| -0.21
| -119.1%
| -117.2%
| -€251.66K
|
| Danaher Corporation
|
trending_up
80
/ 100
| 41
| 14.2%
| 4.2%
| €48.01K
|
| Diaceutics PLC
|
trending_flat
50
/ 100
| -29
| -6.2%
| -7.1%
| -€21.57K
|
| Neuronetics, Inc.
|
trending_flat
50
/ 100
| -4.8
| -43.5%
| -35.9%
| -€57.87K
|
| RadNet, Inc.
|
trending_flat
51
/ 100
| 1.5K
| 0.1%
| 0.1%
| €218.32
|
| Eurofins Scientific SE
|
trending_flat
51
/ 100
| 19
| 4.7%
| 5.3%
| €9.01K
|
| Lonza Group AG
|
trending_flat
51
/ 100
| 30
| 9.5%
| 6.9%
| €78.55K
|
| CareDx, Inc
|
trending_flat
52
/ 100
| 21
| 15.2%
| 11.6%
| €68.85K
|
| Invitae Corporation
|
trending_flat
50
/ 100
| -0.0038
| -299.1%
| -269.2%
| -€727.09K
|
| Twist Bioscience Corporation
|
trending_down
52
/ 100
| -25
| -23.5%
| -13.2%
| -€79.19K
|
| Guardant Health, Inc.
|
trending_down
59
/ 100
| -15
| -49.9%
| -31.1%
| -€177.62K
|
| Neogen Corporation
|
trending_flat
48
/ 100
| -0.93
| -122.1%
| -31.7%
| -€321.21K
|
| MDxHealth SA
|
trending_flat
50
/ 100
| -2.1
| -75.1%
| -35.2%
| -€162.78K
|
| DiaSorin S.p.A.
|
trending_flat
51
/ 100
| 26
| 16.0%
| 0.0%
| €59.40K
|
| Thermo Fisher Scientific Inc.
|
trending_flat
59
/ 100
| 23
| 15.2%
| 6.5%
| €45.19K
|
| Personalis, Inc.
|
trending_flat
48
/ 100
| -6.3
| -113.7%
| -35.3%
| -€343.65K
|
| Charles River Laboratories International, Inc.
|
trending_down
50
/ 100
| -106
| -1.7%
| -0.9%
| -€3.18K
|
| Agilent Technologies, Inc.
|
trending_up
63
/ 100
| 28
| 18.0%
| 10.0%
| €58.48K
|
| HTG Molecular Diagnostics, Inc.
|
trending_flat
50
/ 100
| -0.000011
| -324.3%
| -185.5%
| -€326.23K
|
